Sökning: "Johan Blomquist"

Hittade 3 avhandlingar innehållade orden Johan Blomquist.

  1. 1. Testing Homogeneity and Unit Root Restrictions in Panels

    Författare :Johan Blomquist; Nationalekonomiska institutionen; []
    Nyckelord :SAMHÄLLSVETENSKAP; SOCIAL SCIENCES; Non-stationary panels; Panel unit root tests; Cross-sectional dependence; Homogeneity testing;

    Sammanfattning : This thesis is divided into two distinct parts. The first part contains three chapters, co-authored with Joakim Westerlund, that deal with the analysis of unit root testing, and the second part consists of two chapters on slope homogeneity testing. LÄS MER

  3. 2. Strong Correlation Effects in Bosonic and Fermionic Systems Through an Unbiased Quantum Monte Carlo Approach

    Författare :Emil Blomquist; Egor Babaev; Johan Carlström; Barbara Capogrosso Sansone; KTH; []
    Nyckelord :NATURVETENSKAP; NATURAL SCIENCES; Fysik; Physics; Teoretisk fysik; Theoretical Physics;

    Sammanfattning : Strongly interacting many-body quantum systems constitute some of the most challenging problems in physics, and exact analytical solutions are rare. In this thesis, we will investigate the models of two such systems numerically using the unbiased worm-algorithm Monte Carlo method. LÄS MER

  4. 3. Prognostic Biomarkers and Target Proteins for Treatment of High-grade Gliomas

    Författare :Linda Sooman; Simon Ekman; Johan Lennartsson; Joachim Gullbo; Michael Bergqvist; Erik Blomquist; Stefan Bergström; Beatrice Melin; Uppsala universitet; []
    Nyckelord :MEDICIN OCH HÄLSOVETENSKAP; MEDICAL AND HEALTH SCIENCES; MEDICIN OCH HÄLSOVETENSKAP; MEDICAL AND HEALTH SCIENCES; High-grade glioma; prognostic biomarkers; combination chemotherapy; DNA methylation; FGF2; p38 MAPK; PTPN6; camptothecin; imatinib; vandetanib; EGFR; RAC1; Notch; Medical Science; Medicinsk vetenskap; Oncology; Onkologi;

    Sammanfattning : The survival for high-grade glioma patients is poor and the treatment may cause severe side effects. A common obstacle in the treatment is chemoresistance. To improve the quality of life and prolong survival for these patients prognostic biomarkers and new approaches for chemotherapy are needed. LÄS MER